Cidara Therapeutics Inc. (NASDAQ: CDTX)
$12.82
+0.3200 ( +2.56% ) 25.9K
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
Market Data
Open
$12.82
Previous close
$12.50
Volume
25.9K
Market cap
$59.03M
Day range
$12.18 - $13.06
52 week range
$10.00 - $24.40
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 72 | Nov 02, 2023 |
8-k | 8K-related | 14 | Nov 02, 2023 |
8-k | 8K-related | 15 | Oct 13, 2023 |
8-k | 8K-related | 71 | Sep 21, 2023 |
4 | Insider transactions | 2 | Sep 13, 2023 |
4 | Insider transactions | 1 | Sep 13, 2023 |
8-k | 8K-related | 14 | Sep 06, 2023 |
4 | Insider transactions | 2 | Aug 14, 2023 |
4 | Insider transactions | 1 | Aug 08, 2023 |
8-k | 8K-related | 14 | Aug 03, 2023 |